<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>Characteristics of some metabolic pathway blockers in influenza infection</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Agent</th>
    <th>Target</th>
    <th>Outcome</th>
    <th>Model</th>
    <th>Reference</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>BEZ235</td>
    <td>PI3K/mTOR</td>
    <td>Reconstitution of metabolic status and decreased viral replication</td>
    <td>In vivo</td>
    <td>[
     <xref ref-type="bibr" rid="CR9">9</xref>]
    </td>
   </tr>
   <tr>
    <td>Hochuekkito</td>
    <td>Effect on mitochondrial and glycolysis</td>
    <td>Ameliorates metabolism and intensifies the symptoms</td>
    <td>In vitro</td>
    <td>[
     <xref ref-type="bibr" rid="CR160">160</xref>]
    </td>
   </tr>
   <tr>
    <td>Simvastatin</td>
    <td>Sterol synthesis</td>
    <td>Decreased influenza replication and cytokine production</td>
    <td>In vitro</td>
    <td>[
     <xref ref-type="bibr" rid="CR161">161</xref>]
    </td>
   </tr>
   <tr>
    <td>DADA</td>
    <td>Pyruvate dehydrogenase kinase</td>
    <td>Suppresses cytokine storm and viral replication</td>
    <td>In vivo</td>
    <td>[
     <xref ref-type="bibr" rid="CR94">94</xref>]
    </td>
   </tr>
   <tr>
    <td>MJWQH</td>
    <td>amino acid, fatty acid and arachidonic acid pathway</td>
    <td>Improved weight loss, lung index, biomarkers and inflammatory mediators such as prostaglandin E2</td>
    <td>In vivo</td>
    <td>[
     <xref ref-type="bibr" rid="CR162">162</xref>]
    </td>
   </tr>
   <tr>
    <td>Bezafibrate</td>
    <td>Carnitine palmitoyltransferase II</td>
    <td>Restores the ATP levels in cells and intensifies the symptoms</td>
    <td>In vivo</td>
    <td>[
     <xref ref-type="bibr" rid="CR110">110</xref>]
    </td>
   </tr>
   <tr>
    <td>AM580</td>
    <td>Sterol regulatory element binding protein (SREBP) pathways</td>
    <td>Inhibited influenza virus replication through interference with SREBP paths</td>
    <td>In vivo</td>
    <td>[
     <xref ref-type="bibr" rid="CR105">105</xref>]
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <italic>DADA</italic> Diisopropylamine dichloroacetate, 
   <italic>MJWQH</italic> Modified Jiu Wei Qiang Huo
  </p>
 </table-wrap-foot>
</table-wrap>
